Status:
UNKNOWN
Cardiac Toxicity of Hypo Fractionated Radiotherapy in Left Breast Cancer
Lead Sponsor:
Assiut University
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
18-75 years
Brief Summary
Worldwide, Breast cancer is the most common cancer in women,where 1.7 million new cases diagnosed in 2012 . In 2020 number doubled as 2.3 million women diagnosed with breast cancer. According to ACS 1...
Eligibility Criteria
Inclusion
- 1\. Age 18-75 years old 2. histopathology diagnosed 3. Left sided breast cancer 4. Receiving 3D hypofractionated radiotherapy 5. Patients should be non metastatic 6. performance status 0-2
Exclusion
- • Patient \> 75 years old
- Non histological diagnosed
- Metastatic patient
- Patient with cardiac or other co morbidity.
- ECoG performance status \>2
- pregnant or lactating patients
Key Trial Info
Start Date :
April 27 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05358093
Start Date
April 27 2022
End Date
November 30 2023
Last Update
May 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.